Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 3
1989 2
1990 2
1991 1
1992 5
2000 1
2001 1
2003 2
2004 2
2005 2
2006 1
2007 4
2008 3
2009 3
2010 2
2011 1
2012 2
2014 3
2015 3
2016 3
2017 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

49 results
Results by year
Filters applied: . Clear all
Page 1
Hepatic effects of duloxetine-I: non-clinical and clinical trial data.
Wernicke J, Pangallo B, Wang F, Murray I, Henck JW, Knadler MP, D'Souza DN, Uetrecht JP. Wernicke J, et al. Among authors: knadler mp. Curr Drug Saf. 2008 May;3(2):132-42. doi: 10.2174/157488608784529189. Curr Drug Saf. 2008. PMID: 18690991 Review.
A pharmacokinetic profile of nizatidine in man.
Callaghan JT, Bergstrom RF, Rubin A, Chernish S, Crabtree R, Knadler MP, Obermeyer B, Offen WW, Schneck DW, Aronoff G, et al. Callaghan JT, et al. Among authors: knadler mp. Scand J Gastroenterol Suppl. 1987;136:9-17. doi: 10.3109/00365528709094480. Scand J Gastroenterol Suppl. 1987. PMID: 2892261 Review.
Absorption studies of the H2-blocker nizatidine.
Knadler MP, Bergstrom RF, Callaghan JT, Obermeyer BD, Rubin A. Knadler MP, et al. Clin Pharmacol Ther. 1987 Nov;42(5):514-20. doi: 10.1038/clpt.1987.190. Clin Pharmacol Ther. 1987. PMID: 2890459 Clinical Trial.
49 results